litlas
ログインアカウント作成

Jeffrey Johnson

1987–2026 年に発表

187
論文数
29,923
被引用数
97
h 指数
157
i10 指数

被引用数

Jeffrey Johnson の年別被引用数1988 年: 被引用 2 件1989 年: 被引用 2 件1990 年: 被引用 3 件1991 年: 被引用 1 件1992 年: 被引用 2 件1993 年: 被引用 2 件1994 年: 被引用 2 件1995 年: 被引用 1 件1996 年: 被引用 9 件1997 年: 被引用 17 件1998 年: 被引用 14 件1999 年: 被引用 30 件2000 年: 被引用 39 件2001 年: 被引用 53 件2002 年: 被引用 66 件2003 年: 被引用 88 件2004 年: 被引用 70 件2005 年: 被引用 132 件2006 年: 被引用 173 件2007 年: 被引用 206 件2008 年: 被引用 196 件2009 年: 被引用 196 件2010 年: 被引用 193 件2011 年: 被引用 196 件2012 年: 被引用 276 件2013 年: 被引用 295 件2014 年: 被引用 249 件2015 年: 被引用 271 件2016 年: 被引用 239 件2017 年: 被引用 279 件2018 年: 被引用 233 件2019 年: 被引用 683 件2020 年: 被引用 758 件2021 年: 被引用 875 件2022 年: 被引用 817 件2023 年: 被引用 675 件2024 年: 被引用 1,086 件2025 年: 被引用 476 件2026 年: 被引用 22 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,706 件、この内訳の 22.4%中国: 引用元論文 1,850 件、この内訳の 15.3%イギリス: 引用元論文 939 件、この内訳の 7.8%カナダ: 引用元論文 924 件、この内訳の 7.6%オーストラリア: 引用元論文 486 件、この内訳の 4%オランダ: 引用元論文 402 件、この内訳の 3.3%ドイツ: 引用元論文 393 件、この内訳の 3.2%イタリア: 引用元論文 325 件、この内訳の 2.7%フランス: 引用元論文 313 件、この内訳の 2.6%スペイン: 引用元論文 253 件、この内訳の 2.1%スウェーデン: 引用元論文 181 件、この内訳の 1.5%日本: 引用元論文 174 件、この内訳の 1.4%
0%22.4%その他 26.1%

機関

分野

  • Medicine61.1%
  • Biochemistry, Genetics and Molecular Biology13.2%
  • Computer Science4.7%
  • Health Professions4.6%
  • Economics, Econometrics and Finance4.4%
  • Engineering2.6%
  • その他9.4%

トピック

  • Ferroptosis and cancer prognosis5.6%
  • Cancer, Lipids, and Metabolism2.7%
  • Health Systems, Economic Evaluations, Quality of Life2.5%
  • Metabolism, Diabetes, and Cancer2.3%
  • RNA modifications and cancer2.3%
  • Chronic Disease Management Strategies1.9%
  • その他82.7%

共著者

全論文

検索で開く
  1. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

    著者: Weimin Wang, Michael D. Green, Jae Eun Choi, Miguel A. Gijón, Paul D. Kennedy, Jeffrey Johnson, Peng Liao, Xueting Lang, Ilona Kryczek, Amanda Sell, Houjun Xia, Jiajia Zhou, Gaopeng Li, Jing Li, Wei Li, Shuang Wei, Linda Vatan, Hongjuan Zhang, Wojciech Szeliga, Wei Gu, Rebecca Liu, Theodore S. Lawrence, Candice Lamb, Yuri Tanno, Marcin Cieślik, Everett Stone, George Georgiou, Timothy A. Chan, Arul M. Chinnaiyan, Weiping Zou - Nature 2019 被引用: 2,909

  2. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4

    著者: Peng Liao, Weimin Wang, Weichao Wang, Ilona Kryczek, Li Xiong, Yingjie Bian, Amanda Sell, Shuang Wei, Sara Grove, Jeffrey Johnson, Paul D. Kennedy, Miguel A. Gijón, Yatrik M. Shah, Weiping Zou - Cancer Cell 2022 被引用: 869

  3. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data

    著者: Joshua Z. Goldenberg, Andrew S. Day, Grant D. Brinkworth, Junko Sato, Satoru Yamada, Tommy Jönsson, Jennifer Beardsley, Jeffrey Johnson, Lehana Thabane, Bradley C. Johnston - BMJ 2021 被引用: 421

  4. A meta-analysis of the association between adherence to drug therapy and mortality

    著者: Scot H. Simpson, Dean T. Eurich, Sumit R. Majumdar, Raj Padwal, Ross T. Tsuyuki, Janice Varney, Jeffrey Johnson - BMJ 2006 被引用: 1,361

  5. Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores

    著者: Nathan S. McClure, Fatima Al Sayah, Feng Xie, Nan Luo, Jeffrey Johnson - Value in Health 2017 被引用: 350

  6. Physical activity level and health-related quality of life in the general adult population: A systematic review

    著者: Raphaël Bize, Jeffrey Johnson, Ronald C. Plotnikoff - Preventive Medicine 2007 被引用: 1,159

  7. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada

    著者: Feng Xie, Eleanor Pullenayegum, Kathy Gaebel, Nick Bansback, Stirling Bryan, Arto Öhinmaa, Lise Poissant, Jeffrey Johnson - Medical Care 2015 被引用: 485

  8. US Valuation of the EQ-5D Health States

    著者: James W. Shaw, Jeffrey Johnson, Stephen Joel Coons - Medical Care 2005 被引用: 1,293

  9. Health Literacy and Health Outcomes in Diabetes: A Systematic Review

    著者: Fatima Al Sayah, Sumit R. Majumdar, Beverly Williams, Sandy Robertson, Jeffrey Johnson - Journal of General Internal Medicine 2012 被引用: 398

  10. Long-Term Association Between Frailty and Health-Related Quality of Life Among Survivors of Critical Illness

    著者: Sean M. Bagshaw, Henry T. Stelfox, Jeffrey Johnson, Robert C. McDermid, Darryl Rolfson, Ross T. Tsuyuki, Quazi Ibrahim, Sumit R. Majumdar - Critical Care Medicine 2015 被引用: 267

  11. Comparative Safety and Effectiveness of Metformin in Patients With Diabetes Mellitus and Heart Failure

    著者: Dean T. Eurich, Daniala L. Weir, Sumit R. Majumdar, Ross T. Tsuyuki, Jeffrey Johnson, Lisa Tjosvold, Saskia Vanderloo, Finlay A. McAlister - Circulation Heart Failure 2013 被引用: 337

  12. Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes

    著者: Nathan S. McClure, Fatima Al Sayah, Arto Öhinmaa, Jeffrey Johnson - Value in Health 2018 被引用: 99

  13. Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry

    著者: Michael Pete VanBrunt, Kurt Shanebeck, Zachary Caldwell, Jeffrey Johnson, Pamela Thompson, Thomas Martin, Huifang Dong, Gary Li, Hengyu Xu, François D’Hooge, Luke A. Masterson, Pauline A. Bariola, Arnaud Tiberghien, Ebele Ezeadi, David G. Williams, John A. Hartley, Philip W. Howard, Kenneth H. Grabstein, Michael A. Bowen, Marcello Marelli - Bioconjugate Chemistry 2015 被引用: 142

  14. Type 2 Diabetes and Comorbid Symptoms of Depression and Anxiety: Longitudinal Associations With Mortality Risk

    著者: Kiyuri Naicker, Jeffrey Johnson, Jens Christoffer Skogen, Douglas G. Manuel, Simon Øverland, Børge Sivertsen, Ian Colman - Diabetes Care 2017 被引用: 148

  15. Mortality After Incident Cancer in People With and Without Type 2 Diabetes

    著者: Craig J. Currie, Chris Poole, Sara Jenkins‐Jones, Edwin Gale, Jeffrey Johnson, Christopher Ll. Morgan - Diabetes Care 2012 被引用: 396

  16. Using Instrument-Defined Health State Transitions to Estimate Minimally Important Differences for Four Preference-Based Health-Related Quality of Life Instruments

    著者: Nan Luo, Jeffrey Johnson, Stephen Joel Coons - Medical Care 2010 被引用: 191

  17. Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

    著者: Daniel L. Levin, Samira Bell, Reijo Sund, Sirpa Hartikainen, Jaakko Tuomilehto, ­Eero Pukkala, Ilmo Keskimäki, Ellena Badrick, Andrew G. Renehan, Iain Buchan, Samantha L. Bowker, Jasjeet K. Minhas‐Sandhu, Zafar Zafarí, Carlo A. Marra, Jeffrey Johnson, Bruno H. Stricker, André G. Uitterlinden, Albert Hofman, Rikje Ruiter, Catherine E. de Keyser, Thomas M. MacDonald, Sarah H. Wild, Paul McKeigue, Helen M. Colhoun - Diabetologia 2014 被引用: 155

  18. A multi-level approach for the use of routinely collected patient-reported outcome measures (PROMs) data in healthcare systems

    著者: Fatima Al Sayah, Markus Lahtinen, Gouke J. Bonsel, Arto Öhinmaa, Jeffrey Johnson - Journal of Patient-Reported Outcomes 2021 被引用: 60

  19. Structure of the human marker of self 5-transmembrane receptor CD47

    著者: Gustavo Fenalti, Nicolas Villanueva, Mark T. Griffith, Barbra Pagarigan, Sirish Kaushik Lakkaraju, Richard Y.‐C. Huang, Nadia Ladygina, A. Sharma, David Mikolon, Mahan Abbasian, Jeffrey Johnson, Haralambos Hadjivassiliou, Dan Zhu, Philip P. Chamberlain, Ho Cho, Kandasamy Hariharan - Nature Communications 2021 被引用: 52

  20. Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure

    著者: Dean T. Eurich, Sumit R. Majumdar, Finlay A. McAlister, Ross T. Tsuyuki, Jeffrey Johnson - Diabetes Care 2005 被引用: 421

  21. Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence

    著者: Jeffrey Johnson, Bendix Carstensen, Daniel R. Witte, Samantha L. Bowker, Lorraine L. Lipscombe, Andrew G. Renehan - Diabetologia 2012 被引用: 264

  22. Effect of Vitamin D3Supplementation on Improving Glucose Homeostasis and Preventing Diabetes: A Systematic Review and Meta-Analysis

    著者: Jennifer C Seida, Joanna Mitri, Isabelle N Colmers-Gray, Sumit R. Majumdar, Mayer B. Davidson, Alun Edwards, David A. Hanley, Anastassios G. Pittas, Lisa Tjosvold, Jeffrey Johnson - The Journal of Clinical Endocrinology & Metabolism 2014 被引用: 261

  23. Selection of patient-reported outcome measures (PROMs) for use in health systems

    著者: Fatima Al Sayah, Xuejing Jin, Jeffrey Johnson - Journal of Patient-Reported Outcomes 2021 被引用: 90

  24. Canada population norms for the EQ-5D-5L

    著者: Jiajun Yan, Shitong Xie, Jeffrey Johnson, Eleanor Pullenayegum, Arto Öhinmaa, Stirling Bryan, Feng Xie - The European Journal of Health Economics 2023 被引用: 42